Source: Annual Congress 2013 –COPD treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Korzybski, A. Nowinski, B. Broniarek-Samson, D. Gorecka (Warsaw, Poland). Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory. Eur Respir J 2013; 42: Suppl. 57, 3682

Member's Comments

No comment yet.

Related content which might interest you: Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015 Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Serum heat shock protein levels in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013